October is the new date set by the Girona-based company Hipra to obtain authorisation for its vaccine against covid-19. The company's R&D director, Èlia Torroella, had said that they expected to receive the European Medicines Agency's (EMA) approval between June and July, but they have now been asked for more data. "The situation has been changing and different requirements have been made at different times, and in our case they have asked us to provide more information. We know what they want, we will provide it, and we are convinced that the vaccine will be part of vaccination plans in the autumn," Torroella emphasised, in reference to the Ministry of Health's plans to start administering the fourth dose to the over 60 and to healthcare personnel after the summer.